TNXP
Tonix Pharmaceuticals Holding Corp
9.70$
-5.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.3% | -34.3% | -11.0% | +27.8% | -8.5% | -5.9% | -17.7% | +64.7% | +63.8% | +27.6% | +96.9% | – | |
| – | -0.3% | -29.9% | +102.8% | -53.8% | -23.9% | -20.3% | +247.0% | -58.2% | +13.1% | +38.0% | -67.0% | – | |
| – | -12.6% | -41.8% | -241.0% | – | +10.4% | +6.2% | -185.7% | – | +99.9% | +23.4% | +170.6% | – | |
| – | -18.7% | -24.9% | -24.6% | -6.0% | -9.0% | -10.4% | +45.5% | -14.1% | +82.4% | +7.5% | +6.6% | – | |
| – | +33.4% | -19.9% | -19.4% | +2.7% | -55.9% | +197.2% | +60.4% | +58.6% | +2.4% | +8.8% | +25.6% | – | |
| – | +4.5% | -28.7% | -22.4% | -2.2% | +42.0% | -26.5% | +54.1% | +29.5% | +49.0% | -11.2% | +19.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.